Jiwestone Medical Centre

04/01/2019

02/07/2018

29/03/2016

We have touched base literally .

28/03/2016

We are now occupying the downer floor as well. This is for bettering our services.

28/10/2015

BARCELONA, Spain — Every person infected with HIV should be treated with antiretroviral therapy immediately after diagnosis, according to updated guidelines from the European AIDS Clinical Society (EACS), unveiled here at the 15th European AIDS Conference.

The update also endorses pre-exposure prophylaxis for HIV-negative men who have s*x with men and for transgender people who use condoms inconsistently with casual partners or with HIV-positive partners who are not on treatment.

Prophylaxis can also be considered for HIV-negative heteros*xual women and men who use condoms inconsistently and who are likely to have HIV-positive partners not on treatment, on either a continuous or on-demand basis.

The recommendations in the guidelines, which are updated annually, closely resemble those in the guidelines released by the World Health Organization on September 30, as reported in Medscape Medical News.

26/10/2015

JiweStone Medical Centre was humbled to be part of this activity.

22/10/2015

The Medical Care Criteria Committee of the New York State Department of Health AIDS Institute has released an important update to its guideline "Diagnosis and Management of Acute HIV Infection". Specifically, the revised guideline includes a recommendation to start antiretroviral therapy (ART) in all patients at the time of diagnosis of HIV infection, as well as updated recommendations for diagnosing acute HIV.

On the basis of accumulating data on the pathogenesis of acute HIV infection and data from key studies on treatment and prevention, the committee has concluded that the known and potential benefits of starting ART at the time of diagnosis outweigh the known risks. Strong evidence supports initiation of ART during acute infection to reduce the size of the viral reservoir, prevent or reduce disruption of gut tissue, preserve immune function, suppress virus to undetectable levels in the plasma more rapidly, and potentially reduce morbidity in those with symptomatic acute infection, a group known to be at higher risk for progression. All of these treatment effects can be reasonably expected to provide both short- and long-term clinical benefits for the patient.

There is also strong evidence that reduced plasma viremia correlates with a reduction in transmission. Randomized controlled trials have demonstrated nearly full protection from HIV transmission among serodiscordant heteros*xual couples.

Medscape

08/10/2015

07/10/2015

WHO Guidelines: Everyone With HIV Should Receive ART

All people infected with HIV should receive antiretroviral therapy (ART) as soon as possible, and those at "substantial" risk should be offered pre-exposure prophylaxis (PrEP), according to new guidelines published September 30 by the World Health Organization.
"These recommendations are a major step forward in the global fight against HIV. They have the potential to dramatically reduce transmission of HIV worldwide, increase the widespread use of PrEP among those who need it most, and help those living with HIV live longer, healthier lives," the Centers for Disease Control and Prevention stated in a news release lauding the new WHO recommendations. The Infectious Diseases Society of America and the HIV Medicine Association also announced their support for the guideline.
In the previous WHO guidelines, ART was recommended for people who met a threshold for CD4 cell count and for vulnerable groups such as those with tuberculosis and pregnant women. Those limitations have now been removed, which the World Health Organization estimates will increase the number of people eligible for treatment from 28 million to all 37 million living with the virus globally. They also project that the new measures will prevent 21 million deaths and 28 million new infections by 2030.
The new recommendations, based on evidence available through June 2015, are being released early. They are part of a guideline update scheduled to be published in 2016.
Evidence informing the new recommendations includes the Benefits and Risks of Early Antiretroviral Therapy in HIV-infected Adults in Abidjan, Côte d'Ivoire (ANRS 12136 TEMPRANO) clinical trial, which found that initiating treatment while CD4 counts are still high reduces death, AIDS incidence, and severe non-AIDS diseases. People with CD4 counts below 350 cells/mm3 are considered high priority for initiating treatment.
To fully implement the new recommendations, the report says, countries need to ensure that testing and treatment are available and to provide good linkage to care and support to make sure people adhere to treatment.
PrEP, including with tenofovir, is now recommended for everyone at substantial risk of contracting HIV; previously it was only recommended for certain groups, including men who have s*x with men and people whose partners had HIV. Substantial risk is defined as at least three per 100 person-years; the forthcoming guideline will include information about identifying people most at risk.
PrEP "should be promoted as a positive choice among people for whom it is suitable and their communities," the authors write, emphasizing that it should not "displace or threaten" other preventative programs, such as those promoting condom use.
Medscape

23/09/2015

In Uganda, HIV is spread primarily through unprotected s*xual in*******se. Changing behaviour to promote safer s*xual
practices, including condom use, is therefore fundamental to controlling the epidemic.
Male and female condoms are key because they are currently the
only barrier methods that protect against s*xually transmitted infections (STIs), including HIV. Correct and consistent condom use is one of the most effective means of preventing s*xual transmission of HIV, and it belongs at the heart of HIV prevention in addition to abstinence and faithfulness to one's s*xual partner.
At Jiwestone Medical Centre, we are offering you for free high quality condoms- both male and female condoms.

12/09/2015

We are offering free Safe Male Circumcision (SMC) to young males ages 15 - 24. Strictly by appointment.

02/04/2015

At Jiwestone Medical Centre we are proficient at offering HIV care services. Wishing you a very happy Easter.